Botox 200 unit vials

Ended Awarded

Contract number
SPE2DR26FCGC6
Awardee
Awarding agency
Obligated
$33,008

Award facts

Contract value 100% obligated
$33,008.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $33,008 delivery order to DMS Pharmaceutical Group Inc. on June 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of BOTOX 200 unit vials.

DMS Pharmaceutical Group Inc. is a woman-owned small business. PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. Place of performance is Park Ridge, IL. This delivery order has a firm fixed price and ultimate completion date of July 6, 2026.

Quick answers

Who was awarded contract SPE2DR26FCGC6?

SPE2DR26FCGC6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 11, 2026.

How much is contract SPE2DR26FCGC6 worth?

The government has obligated $33,008 on SPE2DR26FCGC6.

Is contract SPE2DR26FCGC6 an order under another contract?

Yes. SPE2DR26FCGC6 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.

Was contract SPE2DR26FCGC6 competed?

The extent of competition for SPE2DR26FCGC6 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award